secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001665988-25-000032
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus appoints Ajay Dhankhar to board as Smith & Nephew designee
--------------------------------------------------------------------

- Appointment effective November 14, 2025; Dhankhar serves as Class II director until 2026 annual meeting.
- Dhankhar is Chief Corporate Development & Strategy Officer at Smith & Nephew (SNN) since June 2025.
- He is the second designee from S+N stockholders under the Stockholders Agreement.
- Dhankhar will not receive any compensation from Bioventus for board service.
- No family relationships or material interests in any transaction with the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000166598825000032/0001665988-25-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000166598825000032/bvs-20251114.htm
  HTML page:      https://secwatch.observer/filing/0001665988-25-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer